Name:	ions_AssumedChangeInEstimatedSellingPriceOfProduct
Namespace Prefix:	ions_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the average period for completion of an animal study or clinical trial.

No definition available.

Name:	ions_AverageDurationToCompletion
Namespace Prefix:	ions_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The amount of change to the allocation of the consideration to a specific unit of accounting that would result from a specified change in the selling price factor applied to a multiple-deliverable arrangement.

No definition available.

Name:	ions_ChangeInAmountOfRevenueFromProductForAssumedChangeInSellingPrice
Namespace Prefix:	ions_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Revenue from arrangements that include licensing and royalty revenues, profit sharing and/or earn out payments. Licensing revenue represents revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements typically include, but are not limited to, rights to use intellectual property on an exclusive or non-exclusive basis. Royalty, profit sharing and/or earn out payments are derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's intellectual property.

No definition available.

Name:	ions_LicensingAndRoyaltyRevenue
Namespace Prefix:	ions_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of categories of milestone events.

No definition available.

Name:	ions_NumberOfCategoriesOfMilestoneEvents
Namespace Prefix:	ions_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of stages in the life-cycle of drugs, reflected in the categories of contractual milestones.

No definition available.

Name:	ions_NumberOfStagesOfLifeCycleOfDrugs
Namespace Prefix:	ions_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of active collaborations with the collaborative partner.

No definition available.

Name:	ions_NumberOfStrategicCollaborations
Namespace Prefix:	ions_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of targets for the research and development of drugs under a collaborative agreement.

No definition available.

Name:	ions_NumberOfTargetsForCollaborativeAgreement
Namespace Prefix:	ions_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

The percentage change to the allocation of the consideration to a specific unit of accounting that would result from a specified change in the selling price factor applied to a multiple-deliverable arrangement.

No definition available.

Name:	ions_PercentageChangeInAmountOfRevenueFromProductForAssumedChangeInSellingPrice
Namespace Prefix:	ions_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the typical period within which approval is obtained once regulatory filings have been prepared and submitted.

No definition available.

Name:	ions_PeriodForObtainingRegulatoryApproval
Namespace Prefix:	ions_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the typical period within which regulatory filings are prepared and submitted.

No definition available.

Name:	ions_PeriodForPreparingAndSubmittingFilings
Namespace Prefix:	ions_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents a pre-specified sales threshold that could be used as a pre-specified event to trigger a milestone payment.

No definition available.

Name:	ions_PreSpecifiedSalesThreshold
Namespace Prefix:	ions_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of separate units of accounting requiring the allocation of consideration for revenue recognition purposes under the multi-deliverable arrangement.

No definition available.

Name:	ions_RevenueRecognitionMultiDeliverableArrangementNumberOfUnitsOfAccounting
Namespace Prefix:	ions_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Term of the collaboration agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Name:	ions_TermOfCollaborationAgreement
Namespace Prefix:	ions_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The portion of upfront fees received during the period under the terms of the agreement that are recognized as revenue during the period.

No definition available.

Name:	ions_UpfrontFeeRecognized
Namespace Prefix:	ions_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of upfront payments received during the period under the agreement.

No definition available.

Name:	ions_UpfrontPaymentReceived
Namespace Prefix:	ions_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section A

Name:	us-gaap_DeferredRevenueAdditions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- References

No definition available.

Name:	us-gaap_RevenueRecognitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=ions_CollaborativeArrangementsAndLicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ions_AchievementOfMilestoneAxis=ions_DevelopmentMilestonesNewDevelopmentCandidateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ions_AchievementOfMilestoneAxis=ions_DevelopmentMilestonesPhaseOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ions_AchievementOfMilestoneAxis=ions_DevelopmentMilestonesPhaseTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ions_AchievementOfMilestoneAxis=ions_DevelopmentMilestonesPhaseThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ions_AchievementOfMilestoneAxis=ions_RegulatoryMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	ions_AchievementOfMilestoneAxis=ions_CommercializationMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=ions_BayerHealthCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=ions_AgreementEnteredIntoInMay2015Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=ions_IONISFXIMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=ions_IONISFXIActivePharmaceuticalIngredientMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=ions_BiogenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=ions_CollaborativeArrangementJanuary2012Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=ions_NusinersenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=ions_CollaborativeArrangementJune2012Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=ions_IONISDMPK25Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=ions_CollaborativeArrangementDecember2012Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=ions_NeurologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=ions_CollaborativeArrangementSeptember2013Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=ions_StrategicNeurologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: